003 Real World Data Access for Label Expansion and Drug Discovery
Release Date: 04/29/2021
BC Platforms Podcast
Dr. Carolin Bender, Chief Medical Officer for BC Platforms speaks with On Air Media Group about the groundbreaking ONCOVALUE project in collaboration with Helsinki University Hospital (HUS) and other European institutions, that seeks to explore and leverage real-world data (RWD) in the context of cancer research and treatment, and it's dedication to developing an AI-based framework that assesses the real-time, real-life effectiveness of novel cancer therapies.
info_outlineBC Platforms Podcast
Today's episode will focus on the topic of using genomics to accelerate drug development. Our host is Tõnu Esko, BC Platforms SAB Chairman and Vice Director of the Institute of Genomics University of Tartu, where he also holds a Professor of Human Genomics position. He is head of the Estonian Biobank Innovation Center and focuses on public private partnerships and innovation transfer. Dr. Esko is also a research scientist at the Broad Institute of Harvard at MIT. He acts as one of the senior leaders for Estonian personalized medicine programs and serves as a scientific advisor for...
info_outlineBC Platforms Podcast
Today's podcast will focus on the topic of accelerated insights from data for preventative health innovation. The podcast sheds light on industry challenges and expectations as well as innovative approaches to collaboration. This discussion is led by Tõnu Esko, BC Platforms SAB Chairman and Vice Director of the Institute of Genomics University of Tartu, where he also holds a Professor of Human Genomics position. He is head of the Estonian Biobank Innovation Center and focuses on public private partnerships and innovation transfer. Dr. Esko is also a research scientist at the Broad...
info_outlineBC Platforms Podcast
Today's podcast will focus on the topic of the journey to a safe and secure global data access. This podcast sheds light on industry challenges and expectations, as well as innovative approaches to collaboration. The discussion is led by Tõnu Esko, BC Platforms Scientific Advisory Board Chairman, and Vice Director of the Institute of Genomics at the University of Tartu, where he also holds a Professor of Human Genomics position. He is the Head of Estonian Biobank Innovation Center, and focuses on public-private partnerships and innovation transfer. Dr. Esko is also a research scientist at the...
info_outlineBC Platforms Podcast
Today's episode will focus on the topic of real world data access for label expansion. We are holding an open discussion with a few key leaders on how real world data can be applied in drug development to enhance research and accelerate discoveries. This podcast sheds light on industry challenges and expectations, as well as innovative approaches to collaboration. The discussion is led by Tõnu Esko, BC Platforms Scientific Advisory Board Chairman, and Vice Director of the Institute of Genomics at the University of Tartu, where he also holds a Professor of Human Genomics position. He is...
info_outlineBC Platforms Podcast
Welcome to the BC Platforms Podcast! BC Platforms is the global leader in providing a powerful data discovery and analytics platform, as well as data science solutions for personalized health care. BC Platforms enables cross-functional collaboration with our global federated network of data partners. This episode is an open discussion with three key leaders in the healthcare data industry. Tõnu Esko is the Professor of Human Genomics at the University of Tartu, and the longtime leader and member of the Senior Management Board for the Estonian Biobank. Sirpa Soini is...
info_outlineBC Platforms Podcast
Welcome to the first episode of the BC Platforms podcast! BC Platforms is the global leader in providing a powerful data discovery and analytics platform, as well as data science solutions for personalized health care. BC Platforms enables cross-functional collaboration with our global federated network of data partners. In today’s episode we are discussing shaping a data access framework for population health. We will shed light on industry challenges and expectations, as well as innovative approaches to collaboration. This episode is hosted by Tõnu Esko, BC Patforms SAB Chairman and Vice...
info_outlineToday's episode will focus on the topic of real world data access for label expansion. We are holding an open discussion with a few key leaders on how real world data can be applied in drug development to enhance research and accelerate discoveries. This podcast sheds light on industry challenges and expectations, as well as innovative approaches to collaboration.
The discussion is led by Tõnu Esko, BC Platforms Scientific Advisory Board Chairman, and Vice Director of the Institute of Genomics at the University of Tartu, where he also holds a Professor of Human Genomics position. He is the Head of Estonian Biobank Innovation Center, and focuses on public-private partnerships and innovation transfer. Dr. Esko is also a research scientist at the Broad Institute of Harvard and MIT. He acts as one of the senior leaders for Estonian Personal Medicine Program and serves as scientific advisor for several companies.
Our speaker today is Jacek Nowak, Amgen's Executive Medical Director for European Midsize Markets. Jacek has been active as a pharmaceutical industry leader for over 25 years. Prior to joining Amgen in 2003, Jacek served as Medical Director for Central Europe at Wyeth, and he also worked as a Medical Doctor at the Cardiology and Intensive Care Unit at the University Hospital of Slaskie School of Medicine in Katowice, Poland. Jacek holds a degree of Medical Doctor and earned his doctorate on research work on leptin receptor polymorphism. Jacek holds a Diploma in Pharmaceutical Medicine from the Royal College of Physicians in London. His expertise pertains to the area of organ transplantation, oncology, cardiology and metabolic disorders.
What Is Covered:
- What Real World Data is and how it’s connected with drug development
- The opportunity of supplementing randomised clinical trial analysis with the application of real world data
- The complexity of working with different countries, healthcare systems, and different ways in which the data is collected, in order to use the real world data in decision making process
- Expectations towards the real world data and the key properties that big data banks and healthcare systems should keep in mind when partnering with the industry in this space
- Wearables in medicine, telemedicine, digitalization of data, and other personalised medicine trends for the future of healthcare and data research
Resources:
- Amgen https://www.amgen.com/
- The Estonian Biobank https://genomics.ut.ee/en
Connect with Jacek Nowak:
- https://www.linkedin.com/in/jacek-nowak-121684/
Connect with Dr. Tõnu Esko:
- https://www.linkedin.com/in/tõnu-esko-24511524/
Connect with BC Platforms: